Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cholesterol Metabolism—Impacts on SARS-CoV-2 Infection Prognosis, Entry, and Antiviral Therapies

Congwen Wei, View ORCID ProfileLuming Wan, Yanhong Zhang, Chen Fan, Qiulin Yan, Xiaoli Yang, Jing Gong, Huan Yang, Huilong Li, Jun Zhang, Zhe Zhang, Rong Wang, Xiaolin Wang, Jin Sun, Yulong Zong, Feng Yin, Rui Zhang, Qi Gao, Yuan Cao, Hui Zhong
doi: https://doi.org/10.1101/2020.04.16.20068528
Congwen Wei
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luming Wan
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luming Wan
Yanhong Zhang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen Fan
2Department of Laboratory Medicine, the 960th Hospital of PLA, Jinan, 250031, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiulin Yan
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoli Yang
3Department of Clinical Laboratory, the Third Medical Centre, Chinese PLA General Hospital, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Gong
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huan Yang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huilong Li
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Zhang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhe Zhang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rong Wang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaolin Wang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Sun
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yulong Zong
4Department of Laboratory Medicine, Taian City Central Hospital, Taian, 271000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Yin
5Department of Laboratory Medicine, Taian City Central Hospital Branch, Taian, 271000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rui Zhang
6Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, 110042, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qi Gao
7Hotgen Biotech Co., Ltd. Beijing, 102600, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gaoqi@hotgen.com labs.net@gmail.com towall@yahoo.com
Yuan Cao
2Department of Laboratory Medicine, the 960th Hospital of PLA, Jinan, 250031, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gaoqi@hotgen.com labs.net@gmail.com towall@yahoo.com
Hui Zhong
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gaoqi@hotgen.com labs.net@gmail.com towall@yahoo.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The recently emerged pathogenic SARS-coronavirus 2 (SARS-CoV-2) has spread rapidly, leading to a global pandemic. In this study, we show that SARS-CoV-2 infection was associated with clinically significant lower level of HDL cholesterol (HDL-C), which can be used as indicators of disease severity and poor prognosis. Importantly, we found the spike protein of SARS-CoV-2 (SARS-2-S) bound to HDL. Antagonists of HDL receptor-Scavenger receptor class B type I (SR-B1), strongly inhibited SARS-CoV-2 infection. Notably, the lipids transfer function of SR-B1 was indispensable for this inhibition, offering explanations for the reduced serum HDL level observed in COVID-19 patients. Basing on findings here, we speculate that SR-B1-mediated pulmonary HDL-vitamin E uptake could participate in mediating SARS-CoV-2 infection of lung cells, and the unique expression profile of SR-B1 may also affect SARS-CoV-2 cell and tissue tropism. These findings might help to provide further insights into viral transmission, pathological characteristics and reveal therapeutic targets.

Figure1
  • Download figure
  • Open in new tab

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

This is a single center based retrospective study, not a clinical trial

Funding Statement

This study was supported in part by grants from the National Key Research and Development Program of China (2018YFA0900800) and the National Natural Science Foundation of China (31670761, 31872715 and 81773205).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data, models, or code generated or used during the study are available from the corresponding author by request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 24, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cholesterol Metabolism—Impacts on SARS-CoV-2 Infection Prognosis, Entry, and Antiviral Therapies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cholesterol Metabolism—Impacts on SARS-CoV-2 Infection Prognosis, Entry, and Antiviral Therapies
Congwen Wei, Luming Wan, Yanhong Zhang, Chen Fan, Qiulin Yan, Xiaoli Yang, Jing Gong, Huan Yang, Huilong Li, Jun Zhang, Zhe Zhang, Rong Wang, Xiaolin Wang, Jin Sun, Yulong Zong, Feng Yin, Rui Zhang, Qi Gao, Yuan Cao, Hui Zhong
medRxiv 2020.04.16.20068528; doi: https://doi.org/10.1101/2020.04.16.20068528
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Cholesterol Metabolism—Impacts on SARS-CoV-2 Infection Prognosis, Entry, and Antiviral Therapies
Congwen Wei, Luming Wan, Yanhong Zhang, Chen Fan, Qiulin Yan, Xiaoli Yang, Jing Gong, Huan Yang, Huilong Li, Jun Zhang, Zhe Zhang, Rong Wang, Xiaolin Wang, Jin Sun, Yulong Zong, Feng Yin, Rui Zhang, Qi Gao, Yuan Cao, Hui Zhong
medRxiv 2020.04.16.20068528; doi: https://doi.org/10.1101/2020.04.16.20068528

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (75)
  • Allergy and Immunology (194)
  • Anesthesia (54)
  • Cardiovascular Medicine (487)
  • Dentistry and Oral Medicine (89)
  • Dermatology (56)
  • Emergency Medicine (167)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5648)
  • Forensic Medicine (3)
  • Gastroenterology (215)
  • Genetic and Genomic Medicine (855)
  • Geriatric Medicine (87)
  • Health Economics (229)
  • Health Informatics (755)
  • Health Policy (385)
  • Health Systems and Quality Improvement (250)
  • Hematology (105)
  • HIV/AIDS (181)
  • Infectious Diseases (except HIV/AIDS) (6437)
  • Intensive Care and Critical Care Medicine (387)
  • Medical Education (116)
  • Medical Ethics (28)
  • Nephrology (90)
  • Neurology (844)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (161)
  • Occupational and Environmental Health (256)
  • Oncology (514)
  • Ophthalmology (162)
  • Orthopedics (44)
  • Otolaryngology (105)
  • Pain Medicine (45)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (247)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (112)
  • Psychiatry and Clinical Psychology (958)
  • Public and Global Health (2216)
  • Radiology and Imaging (374)
  • Rehabilitation Medicine and Physical Therapy (171)
  • Respiratory Medicine (310)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)